Big Pharma Dividends
| PRM Stock | CAD 13.30 0.18 1.37% |
As of the 1st of December 2024, Dividend Paid And Capex Coverage Ratio is likely to grow to 5.91, while Dividends Paid is likely to drop about 1.5 M. Big Pharma's past performance could be the main factor of why investors trade Big Pharma Split stock today. Investors should clearly understand every aspect of the Big Pharma dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Big Pharma's dividend schedule and payout information. Big Pharma Split dividends can also provide a clue to the current valuation of Big Pharma.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 2.1 M | 1.5 M | |
| Dividend Yield | 0.13 | 0.12 | |
| Dividend Payout Ratio | (15.10) | (14.34) | |
| Dividend Paid And Capex Coverage Ratio | 5.62 | 5.91 |
Big |
Investing in dividend-paying stocks, such as Big Pharma Split is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Big Pharma must own a stock before its ex-dividend date to receive its next dividend.
Big Pharma Expected Dividend Income Per Share
Dividend payment represents part of Big Pharma's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Big Pharma. Big Pharma's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.67 Bottom Scenario | C$0.71 | $0.75 Top Scenario |
One Year
Big Pharma Split expected dividend income per share adjusted for ongoing price standard deviation